Form D · Biotechnology

ANULEX TECHNOLOGIES INC

Minnetonka, MN · CIK 0001161681

Offering snapshot reported Jun 3, 2010 · SEC filing

Reported sold
$18.3M
Offering amount: $20M
Investors reported
14
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 21, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 3, 2010Initial$18,262,966No comparison14SEC filing
Mar 17, 2010Initial$3,780,000No comparison11SEC filing
May 13, 2009Initial$10,244,751No comparisonNot reportedSEC filing
Aug 7, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-142932

Source: Form D, filed Jun 3, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Buzz Benson Director
Ishmael Bentley Executive
Vic Fabano Executive
Jay Graf Director
A. Jay Graf Director
Steven Griffith Executive
P. Richard Lunsford Director, Executive
Paul Richard Lunsford Director, Executive
Matt Meyer Executive
Timothy Miller Executive
David Noel Executive
Doug Roeder Director
Mike Sherman Director
John Sherman Director
Dale Spencer Director
Dave Stassen Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
5600 Rowland Road Suite 280
Minnetonka, MN, 55343